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Biochemical changes in the 
patient’s plasma after red 
blood cell transfusion
ABSTRACT
Introduction. The study aimed at in vivo assessment of the impact of administered red blood cells (RBCs) concentrates on 
the plasma levels of K+, lactate, pH, Na+, Ca++ and glucose, depending on the volume and age of administered products. 
Biochemical changes occurring during the storage of these products were studied in vitro simultaneously. 
Materials and methods. Arterial blood samples were collected in vivo from patients before and after RBCs transfusion and 
plasma levels of biochemical parameters were determined. A group of 80 RBCs samples was analyzed simultaneously, with 
the samples being equally distributed throughout the recommended storage time of 1–35 days. 
Results. The age of RBCs concentrate results in increased potassium and lactate levels and decreased pH, sodium and 
glucose levels in the RBCs samples. The concentrations were in the following ranges: potassium 4.0–40.5 mmol/L; lactate 
4.1–28.0 mmol/L; pH 7.0–6.65; sodium 137–116 mmol/L; glucose 29.0–14.0 mmol/L. A prospectively selected group of 46 
patients were administered a total of 354 RBCs units. The mean age of RBCs concentrates was 16.18 days. The number of 
administered RBCs units ranged from 2 to 38, a mean of 7.7 RBCs units/patient. The administration of 1 RBCs unit was asso-
ciated with a mean in vivo increase of the potassium level by 0.07 mmol/L and lactate level by 0.13 mmol/L. 
Conclusion. The administration of larger amounts of RBCs concentrates may lead to an increase in the patient’s plasma levels 
of potassium and lactate. This increase is proportional to the age and volume of RBCs.
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Introduction
Acute bleeding is frequently associ-
ated with the need for transfusion 
of blood derivatives, especially red 
blood cells (RBCs). The administra-
tion of transfusion products contain-
ing cellular elements poses many 
risks and potential adverse effects. 
Due to the gradual decomposition of 
RBCs and as a result of the accumu-
lation of products of cellular metabo-
lism, i.e. anaerobic glycolysis, the 
biochemical composition of RBC con-
centrates changes. In particular, there 
is an increase in K+ and lactate levels 
and a simultaneous decrease in pH, 
glucose and Na+ levels. The storage 
time has no impact on Ca++ levels in 
the RBC concentrate.
The changes are proportional to the 
storage time. (1) Large-volume RBC 
transfusion may contribute to changes 
in the patients’ plasma biochemical 
parameters (hyperkalemia) and may 
therefore be related not only to the 
volume of RBC products but also to 
storage duration. (2) Other changes 
include a reduction in red blood cell 
deformability, altered red blood cell 
adhesiveness and aggregability, and 
a reduction in 2,3-diphosphoglycerate 
and ATP. Bioactive compounds with 
proinflammatory effects also accumu-
late in the storage medium. These 
changes reduce posttransfusion via-
bility of red blood cells. The clinical 
effects beyond posttransfusion viability 
are uncertain, but a growing body of 
evidence suggests that the storage 
lesion may reduce tissue oxygen availa-
bility, have proinflammatory and immu-
nomodulatory effects, and influence 
morbidity and mortality. (3)
Objectives
The study aimed at in vivo assessment 
of the impact of administered RBC con-
centrates on the levels of selected bio-
chemical parameters (K+, lactate, pH, 
Na+, Ca++, glucose), depending on 
the volume and age of administered 
products. At the same time, biochemical 
changes occurring during the storage of 
these products were studied in vitro.
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Materials and Methods
Given the methods of data collection, 
ethics committee approval for the study 
protocol was not needed.
In a prospectively selected group of 46 
patients needing RBC replacement and 
transfused with RBCs with various stor-
age times, arterial blood samples were 
analyzed. The plasma levels of K+, lac-
tate, pH, Na+, Ca++ and glucose were 
measured before and after the admin-
istration of RBC products. The samples 
were obtained by collecting 0.5 mL of 
blood from the patients’ arterial cath-
eters using the Marquest Quik Arterial 
Blood Gas (ABG) sampler. The samples 
were analyzed on a Nova Biomedical 
Stat Profile CCX combined acid-base 
analyzer. Excluded were patients with 
renal failure (furosemide diuresis, urea 
> 20 mmol/L, creatinine > 300 mol/L, 
dialysis), manifest hepatic insufficiency 
(liver transaminases elevated to more 
than double the normal value, bilirubin 
> 25 mol/L) and those receiving nora-
drenaline at a dose > 0.1 g/kg/min to 
support their circulation. Also excluded 
were patients who were administered 
sodium bicarbonate during the study 
period or potassium chloride to treat 
their initial hypokalemia.
At the same time, samples of RBCs 
administered to patients were pro-
spectively studied. From a total of 
354 RBC units (bags) administered to 
the patients, 80 units were sampled 
according to the length of storage in 
the blood bank to equally cover the 
entire recommended shelf time. The 
obtained data were plotted to show the 
dependence of the studied biochemi-
cal parameters (K+, lactate, pH, Na+, 
Ca++ and glucose) in stored RBC 
products on their age. All the analyzed 
samples of RBC units met the following 
criteria: volume of 280±50 mL, Hb > 
43 g/U, HCT 50-70%, white blood cells 
(WBC) < 1.2×109/L, platelet count < 
20×109/L, plasma proteins < 2 g/L. 
Although the expiration time of RBC 
products was up to 42 days, they were 
recommended to be used no later than 
35 days from collection. (4) The study 
was carried out in the inpatient ward 
of the Department of Anesthesiology, 
Resuscitation and Intensive Medicine, 
University Hospital Olomouc. The RBC 
concentrates were stored in the blood 
bank under normal conditions at 2-6 °C 
and were delivered to the patient’s bed 
in an insulated box. Within 2 minutes 
from the removal and careful mixing 
of the content of the transfusion bag, 
a 0.5 mL sample of the RBC concen-
trate was taken using the Marquest 
Quik ABG sampler and analyzed on a 
Nova Biomedical Stat Profile CCX com-
bined acid-base analyzer. The obtained 
samples were used to determine the 
dependence of changes in the studied 
parameters on the age of products. 
To preserve 1 RBC concentrate unit of 
the studied samples, 20 mL of SAGM 
(Sodium chloride-Adenine-Glucose-
Mannitol) solution and 100 mL of CPD 
(Citrate-Phosphate-Dextrose) solution 
were used (for the composition of both 
solutions see table 1).
The impact of frequency of adminis-
tration and length of previous storage 
of RBC units on the plasma levels of 
biochemical parameters was assessed 
in vivo.
The results were analyzed by the para-
metric paired t-test and non-paramet-
ric paired Wilcoxon test. Correlation 
between the number of administered 
RBC units and increase in potassium 
and lactate levels was demonstrated by 
the Spearman correlation coefficient. 
Regression analysis was used to fit 
curves showing the dependence of 
plasma concentrations of individual 
biochemical parameters on the amount 
of RBCs administered.
Results
The in vitro group comprised 80 RBC 
unit samples stored for 1–35 days. The 
analyzed samples were equally distrib-
uted throughout the interval so that on 
each day of storage in the blood bank, 
two samples were examined.
1. There was a steady increase in K+ 
levels in the RBC concentrate depending 
on the storage time (table 2, figure 1).
2. There was a gradual decrease in the 
pH of the RBC concentrate depending 
on the storage time (table 2, figure 2).
3. There was a steady increase in 
lactate levels in the RBC concentrate 
depending on the storage time (table 
2, figure 3).
4. There was a decrease in Na+ levels 
depending on the storage time (table 
2, figure 4).
5. The storage time had no impact on 
Ca++ levels in the RBC concentrate 
(table 2).
The in vivo group comprised 46 patients, 
of whom 31 (67.4%) were males with a 
mean age of 56.97 years and 15 (32.6%) 
were females with a mean age of 57.66 
years. The stratification of the group 
according to diagnosis was as follows: 
surgical bleeding in 18 patients (39%) 
and traumatic bleeding in 28 patients 
(61%). The patients were administered 
a total of 354 RBC units, a mean of 
7.71 RBC units/patient, a median of 
6.3 RBC units/patients, range 2–38 
RBC units/patient. The mean storage 
time prior to administration was 16.18 
days, a median of 15.8 days. Women 
received a mean of 6.33 RBC units/
patient (a mean storage time of 15.78 
Table 1. Composition of RBC (red blood cell) preservation solutions.
100 mL of CPD solution contain
citric acid (anhydrous) 0.299 g
sodium citrate (dihydrate) 2.63 g
monobasic sodium phosphate (monohydrate) 0.222 g
dextrose (monohydrate) 2.55 g
water for injections q.s.
100 mL of SAGM solution contain
dextrose (monohydrate) 0.900 g




days) and males were given 8.38 RBC 
units/patient on average (a mean stor-
age time of 16.33 days).
6. Increased potassium levels were 
noted in 34 (74%) patients (a mean of 
8.47 RBC units/patient, a mean storage 
time of 16.32 days). In 7 (15%) patients, 
the increase led to hyperkalemia (a 
mean of 11.85 RBC units/patient, a 
mean storage time of 16.78 days). 
Severe hyperkalemia was observed in 1 
patient who had received 38 RBC units 
(a mean storage time of 18.62 days), 
with the potassium level rising from 4.0 
mmol/L to 7.3 mmol/L (table 3). Four 
(9%) patients had their potassium levels 
unchanged (a mean of 2.75 RBC units/
patient, a mean storage time of 14.63 
days). Potassium levels decreased in 
9 (20%) patients (a mean of 6.0 RBC 
units/patient, a mean storage time of 
11.74 days).
It was calculated that in the studied 
group, the administration of a mean of 
7.71 RBC units/patient resulted in an 
increase in the potassium level by 0.54 
mmol/L. That is, the administration of 1 
RBC unit was associated with a mean 
in vivo increase of the potassium level 
by 0.07 mmol/L.
Statistical analysis revealed moder-
ate positive correlation between the 
number of administered RBC units and 
the changes in K+ levels. The increase 
was statistically significant (P = 0.0002) 
(table 4, figure 5).
7. There was a statistically significant 
difference in lactate levels between 
genders. Increased lactate levels were 
observed in 28 (61%) patients. Of those, 
21 (46%) were males (a mean of 10.72 
RBC units/patient, a mean storage 
time of 15.46 days) and 6 (13%) were 
females (a mean of 8.83 RBC units/
patient, a mean storage time of 15.05 
days). There was a decrease in lactate 
levels in 8 (17%) males (a mean of 4.88 
RBC units/patient, a mean storage time 
of 15.79 days) and 9 (20%) females 
(a mean of 4.66 RBC units/patient, a 
mean storage time of 16.09 days). Two 
(5%) males were shown to have no 
changes in lactate levels (a mean of 2 
RBC units/patient, a mean storage time 
of 20 days). It was calculated that the 
administration of 1 RBC unit was in vivo 
associated with a mean increase in lac-
tate levels by 0.2 mmol/L in males and 
with a mean decrease by 0.06 mmol/L 
in females. Statistical analysis showed 
moderate positive correlation between 
the number of administered RBC units 
and the changes in lactate levels. The 
increase was statistically significant (P 
= 0.01) (table 4). The non-parametric 
Mann-Whitney test showed significant-
ly smaller changes in lactate levels in 
females than in males. On average, 
lactate levels rose by 1.52 mmol/L (a 
median of 1.0 mmol/L) in males and 
dropped by 0.16 mmol/L (a median of 
-0.1 mmol/L) in females.
8. No statistically significant changes 
were observed in pH, Na+, Ca++ and 
glucose levels (table 4). When compar-
ing the changes in plasma levels follow-
ing the administration of RBCs, the only 
difference between males and females 
was that in lactate levels. There were 
no differences between genders in the 
other studied parameters.
Discussion
The results showing an increase in 
plasma potassium levels are in accor-
dance with those reported by Aboudara 
et al. in 2008. (5) The study focused 
on hyperkalemia (> 5.5 mmol/L) in a 
group of 131 non-crush trauma patients 
undergoing cardiopulmonary resusci-
tation during the initial 12 hours after 
admission to a hospital. Of those, 96 
(73.3%) patients received RBCs (a 
mean of 11.2 RBC units/patient, range 
1-55 RBC units/patient). Interestingly, 
38.5% of transfusion patients devel-
oped hyperkalemia, as compared with 
only 2.9% of patients without transfu-
sion. The study documented a more 
dramatic rise in potassium levels in 
transfusion (from 3.7 mmol/L to 5.3 
mmol/L) than in non-tranfusion patients 
(from 3.6 mmol/L to 4.0 mmol/L). 
Similar conclusions were published by 
Smith et al. in 2006. They retrospective-
ly reviewed the Mayo Clinic records of 
patients who developed intraoperative 
cardiac arrest associated with hyper-
kalemia during large volume or fast 
RBC transfusion in 1988–2006. Sixteen 
patients were identified (11 adult, 5 
pediatric) who received from 1 (in a 2.7 
kg neonate) to 54 RBC units. The mean 
potassium concentration during car-
diac arrest was 7.2±1.4 mmol/L (range 
5.9–9.2 mmol/L). The mean resuscita-
tion duration was 32 minutes (range 
2–127 mins) and the in-hospital survival 
rate was 12.5%. (6)
With respect to the potential increase 
in potassium levels, the risk is posed 
especially by long-stored RBC concen-
trates. In addition to decomposition of 
RBCs, increased potassium concentra-
tion in older RBC units is determined 
by cold-induced blockade of adenos-
ine triphosphate (ATP). This leads to 
extracellular release of K+ and entry of 
Na+ ions into RBCs. The intracellular 
concentration of potassium ions ranges 
from 100 to 140 mmol/L. (7) The tran-
scellular gradient for K+ between the 
extracellular and intracellular spaces 
is mostly contributed to by Na+/K+-
ATPase (sodium pump) which is inhib-
ited under anaerobic conditions. Under 
physiological conditions, it pumps three 
sodium ions out of the cell for every 
two potassium ions pumped in. Higher 
potassium levels in fresh RBC con-
centrates may also result from muscle 
activity – repeated fist pumping during 
blood collection. This may increase 
serum K+ concentration at the collec-
tion site in the donor’s forearm by more 
than 1 mmol/L. (8) The potassium con-
centrations measured in stored RBCs 
suggest that the recommended maxi-
mum rate of 20 mmol/hour, (9,10) or 
40 mmol/hour in severe hypokalemia, 
(11) may be exceeded. The maximum 
may be achieved by administration of 
a mean of 6 RBC units/hour (a mean 
age of RBCs of 14 days means potas-
sium concentration of 23 mmol/L). With 
a mean hematocrit value in RBCs of 
0.50 and a volume of a transplantation 
unit of 290±20 mL, the total volume 
of extracellular fluid in a RBC unit is 
145 mL and mean total potassium in 
14-day-old RBCs is 3.33 mmol. If the 
RBC storage time is prolonged from 
35 to 42 days, hemolysis of red blood 
cells increases by 30% on average. 
(12) The mean 24-hour posttransfusion 
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recovery of short-stored (1-10 days) 
RBCs was 86.4±17.8% as compared 
with 73.5±13.7% in long-stored (25-35 
days) RBCs. (13) On the other hand, the 
administration of long-stored RBCs has 
no adverse impact on gastric tonometry 
or tissue oxygenation. (14) From the 
currently published data, it is difficult to 
determine whether there is a relation-
ship between the age of transfused 
RBCs and morbidity or mortality in adult 
patients, with the exception of trauma 
patients receiving massive transfusion 
in whom the risk of older RBCs was 
confirmed. (15) Recent studies suggest 
that transfusion of RBCs older than 2 
weeks is related to an increased risk 
of postoperative complications and 
higher mortality. (16-18) Metabolic 
changes in the recipient’s organism, 
such as hyperkalemia, citrate toxicity, 
lactic acidosis or hypothermia, may 
lead to depression of left ventricular 
function. (2) Red blood cells older than 
2 weeks increase both the risk of post-
operative complications and mortal-
ity rates in cardiac surgery patients. 
(19,20) Transfusion of RBCs increases 
cerebral oxygenation in patients with 
severe brain injury, with the exception of 
transfusion of RBCs older than 19 days. 
(21) In reversing the neurocognitive 
deficit of acute anemia, however, RBCs 
stored for 3 weeks are as efficacious as 
those stored for 3.5 hours. Therefore, 
requiring fresh RBCs is not warranted 
in this case. (22) Since new alkaline 
additive solutions have prolonged the 
storage time to 10 weeks, (23) the risk 
of hyperkalemia may be eliminated by 
using potassium adsorption filters prior 
to administration of older RBC concen-
trates. In another study, potassium level 
was 60.6 ± 2.68 mmol/L just before fil-
tration of 28-day-old RBC concentrates. 
After filtration, the level of K+ was only 
3.42±2.91 mmol/L. (24) At present, 
potassium adsorption filters are not 
commonly available in  clinical practice. 
The question arises whether patients 
at risk of hyperkalemia (massive blood 
replacement, renal failure, pre-existing 
hyperkalemia) should be considered 
for administration of short-stored RBCs. 
Other complications related to the use 
of “old” RBCs in critically ill patients 
should also be borne in mind, such as 
transfusion-related immunomodula-
tion, ability to transfer O2, impaired 
deformability of RBCs and their impact 
on the already affected microcircula-
tion, etc. Should preferential selection 
of “young” RBCs for these patients be 
arranged with the blood bank then? The 
age of RBCs administered in the first 6 
hours of blood replacement was shown 
to be an independent risk factor for 
the development of posttraumatic mul-
tiorgan failure. Therefore, fresh blood 
should be required in the initial phase 
of volume resuscitation of traumatized 
patients. (25) 
In the course of the study, a significant 
drop in potassium levels was noted in 
one of the cases. It occurred after the 
initiation of perioperative blood recu-
peration using the Cell Saver system. 
The salvaged blood (returning to the 
patient) was hypokalemic (2.7 mmol/L 
of K+). In the system, suctioned blood 
is washed with heparinized saline con-
taining no potassium. Excess fluid with 
ions and tissue detritus is removed by 
centrifugation. When being returned to 
the patient, blood is not commonly bio-
chemically monitored and decreased 
potassium levels may not be noticed.
In stored RBC concentrate, there is an 
increase in the levels of lactate, a prod-
uct of anaerobic blood cell metabo-
lism. The source of energy, glucose, 
is metabolized by glycolysis to lactate 
using two ATP molecules. When moni-
toring lactatemia in our study, a statis-
tically significant difference between 
genders was observed, with lactate lev-
els rising in males but falling in females. 
There is no satisfactory explanation for 
this finding. At the same time, there is 
a question about misinterpretation of 
lactate levels as a marker of shock and 
its successful therapy in patients with 
massive transfusion.
Decreased levels of ionized calcium 
in citrate intoxication and thus clinical 
signs of hypocalcemia resulting from 
transfusion of citrate blood derivatives 
are rare. In such cases, 10 mL of 10% 
CaCl2 may be administered. Howev-
er, routine administration of calcium 
remains a matter of controversy. In the 
recipient’s organism, citrate binds to 
calcium, resulting in decreased levels 
of ionized calcium. The clinical signs 
of citrate toxicity (depression of myo-
cardial inotropy, prolonged QT inter-
val, decreased vascular resistance) 
may occur if citrated blood products 
are administered at a rate of more 
than 100mL/minute or, in patients with 
hepatopathy, even at a lower rate. (26)
No changes in pH of patients due to 
transfusion of RBCs with low pH were 
recorded although acidification may 
result from both lactate, a metabolite of 
anaerobic glycolysis of RBCs, and low 
pH of citrate preservative solution. The 
lowered pH of stored blood is also likely 
to be caused by a gradual increase in 
pCO2. However, transfusion may be 
followed by manifestations of metabolic 
alkalosis after citrate is converted to 
bicarbonate. Thus, the final shift in pH 
depends both on the rate and volume 
of transfusion and on the metabolic 
function of the liver. (26) The rate of 
administration of RBC concentrate is 
dependent on patient tolerance. The 
highest recommended rate is 100 mL/
min while the slowest administration 
of 1 RBC unit may take as much as 4 
hours (the risk of bacterial contamina-
tion). If slower application is needed (in 
patients with cardiac failure), the blood 
bank should be asked for providing 
smaller bags. (27)
The reason for decreased in vitro Na+ 
concentration in RBCs is that the pro-
cess of K+/Na+ exchange between 
the intracellular and extracellular spac-
es is inhibited during storage of RBCs. 
However, decreased sodium levels in 
RBCs have no effect on in vivo sodium 
concentration after transfusion. This is 
likely because the decrease in sodium 
levels in RBCs is not substantial.
The decrease of 2,3-diphosphoglycer-
ate (DPG) in RBCs is proportional to 
the storage time. It results in the shift 
of the hemoglobin dissociation curve to 
the right and increased affinity of hemo-
globin for oxygen, leading to decreased 
release of oxygen to tissues and a risk 
of tissue hypoxia. In addition to 2,3-
DPG reduction, RBC storage leads 
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Table 2. Mean K+, pH, lactate, Ca++, Na+ and glucose concentrations in bags on storage days 1 to 35.
day 1 3 7 10 14 18 21 24 28 31 35
pH 7.00 6.95 6.93 6.91 6.85 6.83 6.78 6.75 6.71 6.68 6.65
K+ (mmol/L) 4 10 12 22 23 29 31 32 33 38 40
lactate (mmol/L) 4.1 10.0 14.0 17.0 18.0 22.0 23.0 25.0 26.0 27.0 28.0
glucose (mmol/L) 29 28 27 26 25 24 23 20 18 16 14
Ca++ (mmol/L) 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17
Na+ (mmol/L) 137 135 133 130 125 123 123 122 120 118 116
Figure 1. Mean K+ concentrations 
in RBC (red blood cell) concentrate 
depending on its age.
Figure 2. pH levels in RBC (red blood 
cell) concentrate depending on its 
age.
Figure 3. Lactate concentration 
(mmol/L) in RBC (red blood cell) con-
centrate depending on its age.
Figure 4. Sodium concentration 
(mmol/L) in RBC (red blood cell) con-
centrate depending on its age.
to decreased deformability of the red 
cells and reduced ATP. These changes 
shorten RBC survival after transplanta-
tion, decrease the availability of tissue 
oxygenation and have proinflammatory 
and immunomodulatory effects. In a 
study of aged packed RBCs used in 
critically injured trauma patients, there 
was a decrease in tissue oxygenation in 
patients receiving RBCs 21 days old or 
older as compared with patients receiv-
ing blood less than 21 days old. Thus, 
factors in stored RBCs may influence 
oxygen delivery. (28) Unfortunately, 
no randomized controlled studies are 
available that would confirm the impact 
of RBC storage time on morbidity and 
mortality. (3) 
Iron overload may occur after repeated 
RBC transfusion. Under normal condi-
tions, daily extraction of iron is approxi-
mately 1 mg. One RBC unit contains 
about 250 mg of iron. Full plasma trans-
ferrin saturation with iron is achieved 
after the administration of 10–15 RBC 
units. Unbound iron may cause organ 
damage by formation of its deposits 
in the myocardial, liver and pancre-
atic tissues. Another problem may be 
the pro-infective effects of iron. How-
ever, iron overload is not associated 
with administration of a single massive 
blood product. (26,29)
The so-called “storage lesions” are 
related not only to biochemical chang-
es. Elevation of anti-inflammatory cytok-
ines and molecular changes (deforma-
tion of the shape and elasticity of RBCs 
followed by impaired microcirculation) 
also occur during storage. Recupera-
tion is capable of removing microaggre-
gates larger than 17 m but not those 
smaller than 7 m. Currently, there is 
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Table 4. Changes in K+, pH, lactate, Na+, Ca++ and glucose concentrations in vivo after the administration of 2–38 (a 
mean of 7.7) RBC (red blood cell) units.
baseline baseline baseline final final final
range median mean±SD range median mean±SD significance
K+(mmol/L) 2.8–6.9 4.25 4.31±0.79 3.0–7.3 4.65 4.85±0.82 < 0.0001




lactate (mmol/L) 0.4–15.2 3.05 4.1±3.38 0.7–16.2 3.35 5.08±4.45 0.01
glucose (mmol/L) 5–23 9.45 10.67±4.33 4.8–21.8 9.2 10.39±4.31 0.429




Na+ (mmol/L) 117–150 138 137±5.5 126–150 139 139±5.6 0.01










pH 6.85 7.40 7.30 7.31
K+ (mmol/L) 23.0 3.0 3.0 2.7
Ca++ 
(mmol/L)
0.17 0.22 0.22 0.23
glucose 
(mmol/L)
25.00 20.00 21.10 0.44
Cell Saver, fresh blood from a salvage system; FFP, fresh frozen plasma; PLTs, apheresis leuko-
cyte-depleted platelet concentrate; RBCs, red blood cells, resuspended, buffy coat removed.
Figure 5. Changes in potassium 
levels after transfusion of various 
numbers of RBC (red blood cell) tran-
sfusion units (TU) (mean RBC age 
16.18 days).
much interest in the immunomodulatory 
effect of transfused RBCs as a poten-
tial mechanism for increased morbidity 
and mortality of hospitalized patients 
after administration of RBCs. The 
mechanism is development of nosoco-
mial infections, acute lung injury or later 
autoimmune diseases. (30,31) Given 
the above risks, transfusions should be 
carefully considered. According to the 
American Association of Blood Banks 
(AABB), the need for transfusion should 
be assessed with respect to parameters 
of the severity of the disease and clinical 
status rather than arbitrary hemoglobin 
levels. (32) There is no single value of 
hemoglobin concentration that justifies 
or requires transfusion. Evaluation of 
the patient’s clinical situation should be 
a factor in the decision (33) since the 
organism is capable of adapting to ane-
mia by increased cardiac output (in the 
absence of volume depletion), changes 
in microcirculation and increased con-
centration of 2,3-DPG (i.e. the shift of 
the hemoglobin dissociation curve to 
the right). (34) There is almost no evi-
dence that routine administration of 
RBCs to non-bleeding patients with 
hemoglobin concentrations greater 
than 70 mg/L results in better outcome. 
(34) This study focused on assessing 
changes in biochemical parameters 
occurring in red blood cells, buffy coat 
removed. Therefore, the results do not 
apply to other blood products such as 
resuspended RBCs, leukocyte-deplet-
ed RBCs and resuspended aphere-
sis RBCs. The other types of blood 
derivatives, such as fresh frozen plas-
ma, apheresis platelets or apheresis 
leukocyte-depleted platelets, contain 
no cellular elements. As compared with 
RBC products, in particular potassium 
and pH values are significantly differ-
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ent (table 5). Therefore, the potential 
impact of the other blood derivatives 
(fresh frozen plasma, platelet concen-
trate) on changes in plasma levels of 
the studied parameters is very likely to 
be negligible. When discussing the out-
comes, the potential effect of many vari-
ables should be taken into account that 
play a role in the patient’s internal envi-
ronment during life-threatening condi-
tions requiring massive transfusion. To 
varying degrees, they contribute to the 
development of hemorrhagic shock 
and may, to a certain extent, skew the 
results. Of particular importance is the 
ability of the buffer systems to com-
pensate for the decrease in pH. Each 
0.1 unit of pH change results in a 0.4 
mmol/L change in the serum potassium 
level (a 0.6 mmol/L change accord-
ing to some authors). (11) Potassium 
levels are increased by acidosis and 
decreased by alkalosis. The resulting 
change in the internal environment also 
depends on the ability of the respira-
tory system to counter the developing 
metabolic acidosis. The renal function 
status, ability of the kidneys to increase 
potassium excretion, either in sponta-
neously maintained diuresis or espe-
cially after the administration of loop or 
osmotic diuretics. (11) Other aspects 
to be taken into account are continued 
blood loss (i.e. loss of relatively hyper-
kalemic blood after transfusion), degree 
of tissue and organ hypoperfusion 
(increasing acidosis on its own) and the 
liver’s ability to convert citrate to bicar-
bonate and lactate to glucose. What 
cannot be overlooked is the potential 
effect of potassium-containing replace-
ment solutions (Plasma-Lyte 5 mmol/L, 
Ringer’s acetate 5 mmol/L, Ringer’s lac-
tate 5 mmol/L, Ringerfundin 4 mmol/L, 
Tetraspan 4 mmol/L; Voluven and saline 
contain no potassium) or alkalizing solu-
tions (Plasma-Lyte) or those maintaining 
neutral pH (Ringerfundin).
Conclusion
The detected changes in the plasma lev-
els of biochemical parameters suggest 
the risk for developing hyperkalemia 
and hyperlactatemia, depending on the 
character of RBC products. The risk 
grows with increases in the volume of 
administered RBCs, duration of transfu-
sion and storage time of the adminis-
tered RBCs. The presented in vivo study 
confirms the published results and doc-
uments the influence of administration of 
long-stored RBCs, especially increased 
K+ and lactate levels. Particularly pos-
sible hyperkalemia may be a life-threat-
ening factor. Intermittent monitoring of 
the patient’s biochemical parameters 
during massive transfusion is advisable. 
In small-volume transfusions, laboratory 
plasma levels should be monitored in 
patients with a limited ability to eliminate 
potassium load (renal insufficiency) or 
in those with pre-existing hyperkalemia. 
In the future, potassium adsorption fil-
ters are likely to be used. Although the 
storage time has a negative impact on 
the biochemical composition of RBCs, 
there is currently insufficient evidence 
to advocate for shorter storage times 
for RBCs. No randomized controlled 
trials studying the effect of storage time 
on morbidity and mortality have been 
published. By contrast, leukoreduction 
improves the quality of RBCs and may 
reduce the adverse effects (impaired 
tissue oxygen availability, proinflamma-
tory and immunomodulatory effects). In 
some studies, it was shown to reduce 
morbidity and mortality.
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